JP5837996B2 - 水和ゲル及び水和ゲルメンブレイン並びにそれらの製造方法 - Google Patents
水和ゲル及び水和ゲルメンブレイン並びにそれらの製造方法 Download PDFInfo
- Publication number
- JP5837996B2 JP5837996B2 JP2014548646A JP2014548646A JP5837996B2 JP 5837996 B2 JP5837996 B2 JP 5837996B2 JP 2014548646 A JP2014548646 A JP 2014548646A JP 2014548646 A JP2014548646 A JP 2014548646A JP 5837996 B2 JP5837996 B2 JP 5837996B2
- Authority
- JP
- Japan
- Prior art keywords
- peg
- polymer network
- hydrated gel
- arm
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012528 membrane Substances 0.000 title claims description 67
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 100
- 229920000642 polymer Polymers 0.000 claims description 41
- 239000007788 liquid Substances 0.000 claims description 37
- 239000000654 additive Substances 0.000 claims description 35
- 230000000996 additive effect Effects 0.000 claims description 35
- 229920005615 natural polymer Polymers 0.000 claims description 33
- 102000008186 Collagen Human genes 0.000 claims description 20
- 108010035532 Collagen Proteins 0.000 claims description 20
- 229920001436 collagen Polymers 0.000 claims description 20
- 230000015556 catabolic process Effects 0.000 claims description 19
- 238000006731 degradation reaction Methods 0.000 claims description 19
- 239000003999 initiator Substances 0.000 claims description 19
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 18
- 125000000524 functional group Chemical group 0.000 claims description 18
- 229920002674 hyaluronan Polymers 0.000 claims description 18
- 229960003160 hyaluronic acid Drugs 0.000 claims description 18
- 238000006065 biodegradation reaction Methods 0.000 claims description 15
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims description 14
- 210000000988 bone and bone Anatomy 0.000 claims description 13
- 230000010478 bone regeneration Effects 0.000 claims description 12
- 230000007547 defect Effects 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 238000001727 in vivo Methods 0.000 claims description 9
- 230000000977 initiatory effect Effects 0.000 claims description 9
- 230000001678 irradiating effect Effects 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 229940114081 cinnamate Drugs 0.000 claims description 7
- 229940113082 thymine Drugs 0.000 claims description 7
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 6
- 229940048053 acrylate Drugs 0.000 claims description 6
- 229940063557 methacrylate Drugs 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 3
- 230000036571 hydration Effects 0.000 claims description 2
- 238000006703 hydration reaction Methods 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 description 60
- 229960005188 collagen Drugs 0.000 description 15
- 238000000034 method Methods 0.000 description 11
- 210000004872 soft tissue Anatomy 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 229920002971 Heparan sulfate Polymers 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940045110 chitosan Drugs 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 229960002086 dextran Drugs 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000010398 acute inflammatory response Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000005548 dental material Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
- B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
- B29C39/003—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor characterised by the choice of material
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/26—Cellulose ethers
- C08L1/28—Alkyl ethers
- C08L1/286—Alkyl ethers substituted with acid radicals, e.g. carboxymethyl cellulose [CMC]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
- C08L101/16—Compositions of unspecified macromolecular compounds the macromolecular compounds being biodegradable
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/02—Dextran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/10—Heparin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2071/00—Use of polyethers, e.g. PEEK, i.e. polyether-etherketone or PEK, i.e. polyetherketone or derivatives thereof, as moulding material
- B29K2071/02—Polyalkylene oxides, e.g. PEO, i.e. polyethylene oxide, or derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0058—Liquid or visquous
- B29K2105/0061—Gel or sol
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
- B29K2995/0037—Other properties
- B29K2995/0088—Molecular weight
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2300/00—Characterised by the use of unspecified polymers
- C08J2300/20—Polymers characterized by their physical structure
- C08J2300/206—Star polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/08—Cellulose derivatives
- C08J2301/26—Cellulose ethers
- C08J2301/28—Alkyl ethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/02—Dextran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/10—Heparin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
- C08J2371/02—Polyalkylene oxides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2400/00—Characterised by the use of unspecified polymers
- C08J2400/20—Polymers characterized by their physical structure
- C08J2400/206—Star polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2471/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
- C08J2471/02—Polyalkylene oxides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2201/00—Properties
- C08L2201/06—Biodegradable
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/04—Polymer mixtures characterised by other features containing interpenetrating networks
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Biophysics (AREA)
- Thermal Sciences (AREA)
- Physics & Mathematics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicinal Preparation (AREA)
- Dental Preparations (AREA)
Description
すなわち、歯科用メンブレインの場合、骨再生が完成される時点まではメンブレイン強度が維持され、骨再生が完成された以後には速く分解されて、最終的に硬組織と軟組織の融合にメンブレインが妨害物でとして作用してはならないが、光重合を利用した水和ゲルタイプのメンブレインは、強い物理的強度を有する半面、適切な時点で分解されにくいという問題点がある。
本発明の他の目的は、従来のシートタイプのメンブレインの使用上の不便さを克服するために骨欠損部の形状に関係なく自由に適用することができる水和ゲルメンブレイン及びその製造方法を提供することにある。
また、光重合が可能な官能基は、アクリレート、メタクリレート、クマリン、チミン及びシンナマートのいずれか一つ以上を使用することができる。
また、光重合開始剤は、400〜750nm波長の可視光線に反応してラジカルを生成することができる。
本発明の水和ゲルは、光重合が可能な官能基を有するPEGと、光重合されたPEGとともに相互侵入高分子網目(IPN)を形成し、PEGより高い粘度と速い生体分解速度を有する天然高分子添加剤と、PEGの光重合を開始するためのラジカルを生成する光重合開始剤と、を含んで構成され、光重合されたPEGと天然高分子添加剤が混合されて形成された相互侵入高分子網目(IPN)形態を有することを特徴とする。
しかし、本発明の水和ゲルを適用したメンブレインの場合、図1に示したとおり、相互侵入高分子網目を構成する天然高分子添加剤が適切な分解時点(target point)で先に分解されながら水和ゲルの内部ネットワーク構造が緩んで、緩んだネットワーク内部に兔疫細胞が容易に浸透して、結果的にメンブレインの速い体内分解が進行される。
すなわち、PEGより速い生体分解速度を有する天然高分子添加剤が体内分解性を主導することにより、水和ゲルの体内分解速度の加速が可能になり、天然高分子の添加を通じて水和ゲル−組職相互間の親和性を増加させて、窮極的には、これを歯科用メンブレインで使用する場合、硬組織と軟組織の融合を促進させることができる。
一方、高分子網目の骨組みを形成するPEGは、〔(−CH2CH2O−)n(ここで nは10〜1,000の自然数)〕の化学式を有する高分子として、好ましくは、分子量範囲内で直鎖状(2−arm)以外にも分枝状(4または8−arm)、星状(multi−arm)のPEGを単独または混合して使用することができる。
また、光重合開始剤は、PEGの光重合を開始するためのラジカルを生成する役目をし、好ましくは、400〜750nm波長の可視光線に反応してラジカルを生成する。
また、水和ゲルを使用したメンブレインは、I)PEGを含む第1の液型及び、天然高分子添加剤と光重合開始剤を含む第2の液型と、を準備する段階と、II)準備された第1の液型と第2の液型を空洞部の中で混合する段階と、III)混合溶液をメンブレイン形態で形象化する段階と、IV)メンブレインに可視光線を加える段階と、を通じて製造することができ、または、I)PEGを含む第1の液型及び、天然高分子添加剤と光重合開始剤を含む第2の液型を準備する段階と、II)準備された第1の液型と第2の液型を空洞部内で混合する段階と、III)混合溶液に可視光線を照射して相互侵入高分子網目(IPN)形態の水和ゲルを形成する段階と、IV)水和ゲルをメンブレイン形態で形象化する段階と、を通じて製造することができる。
このように混合された溶液は、周辺部に流れない程度の粘度を有するので、混合溶液を骨欠損部形態の枠に注射型容器などを利用して塗布するか哺乳類の骨欠損部の部分に直接塗布して適切なメンブレイン形態で自由に形象化することができ、このように形象化されたメンブレインに可視光線を照射して重合させることにより、最終的に相互侵入高分子網目(IPN)形態の水和ゲルメンブレインを製造することができる。
本発明の水和ゲルを歯科用材料で使用する際、上述の注射型容器を利用する方法の外にもペースト容器を利用する方法、直接形象化する方法、鋳型を利用する方法など、本発明の要旨を脱しない限り多様な方法で使用が可能である。
一方、本発明のまた他の実施例では、第1の液型と第2の液型との混合溶液にすぐ可視光線を照射して水和ゲル形態で先に硬化させた後、水和ゲルに適切な圧力を加えて塗布することにより水和ゲルメンブレインを製造するができる。
Claims (7)
- 重合が可能な官能基を有するポリエチレングリコール(polyethylene glycol:以下、PEGと略す)と、
光重合されたPEGとともに相互侵入高分子網目(interpenetrating polymer network:IPNと略す)を形成し、前記PEGより高い粘度と速い生体分解速度を有することにより前記PEGより先に分解されて前記高分子網目の体内分解を促進させる天然高分子添加剤と、
前記PEGの光重合を開始するためのラジカルを生成する光重合開始剤と、を含み、
前記天然高分子添加剤は、ヒアルロン酸とコラーゲンの組み合わせが用いられ、分子量が100,000〜10,000,000であり、
前記PEGは、〔(−CH2CH2O−)n(ここでnは10〜1,000の自然数)〕の化学式を有し、前記分子量範囲内で直鎖状(2−arm)、分枝状(4または8−arm)、星状(multi−arm)のPEGが単独または混合して使用され、
前記光重合が可能な官能基は、アクリレート、メタクリレート、クマリン、チミン及びシンナマートのいずれか一つ以上を含み、
骨再生が完成された後、前記天然高分子添加剤が相互侵入高分子網目内で前記PEGより先に分解されて前記高分子網目の体内分解を促進させ、
骨欠損部に適用されることを特徴とする水和ゲル。 - I)光重合が可能な官能基を有するポリエチレングリコール(polyethylene glycol:以下、PEGと略す。)を含む第1の液型及び、前記PEGより高い粘度と速い生体分解速度を有することにより前記PEGより先に分解されて前記高分子網目の体内分解を促進させる天然高分子添加剤と前記PEGの光重合を開始するためのラジカルを生成する光重合開始剤とを含む第2の液型を準備する段階と、
II)前記準備された第1の液型と第2の液型を空洞部内で混合する段階と、
III)前記混合溶液に可視光線を照射して相互侵入高分子網目(IPN)形態の水和ゲルを形成する段階と、を含み、
前記天然高分子添加剤は、ヒアルロン酸とコラーゲンの組み合わせが用いられ、分子量が100,000〜10,000,000であり、
前記PEGは、〔(−CH2CH2O−)n(ここでnは10〜1,000の自然数)〕の化学式を有し、前記分子量範囲内で直鎖状(2−arm)、分枝状(4または8−arm)、星状(multi−arm)のPEGが単独または混合して使用され、
前記光重合が可能な官能基は、アクリレート、メタクリレート、クマリン、チミン及びシンナマートのいずれか一つ以上を含み、
骨再生が完成された後、前記天然高分子添加剤が相互侵入高分子網目内で前記PEGより先に分解されて前記高分子網目の体内分解を促進させ、
骨欠損部に適用されることを特徴とする水和ゲルの製造方法。 - 前記光重合開始剤は、400〜750nm波長の可視光線に反応してラジカルを生成することを特徴とする請求項2に記載の水和ゲルの製造方法。
- 光重合が可能な官能基を有するポリエチレングリコール(polyethylene glycol:以下、PEGと略す)と、
光重合されたPEGとともに相互侵入高分子網目(interpenetrating polymer network:IPNと略す)を形成し、前記PEGより高い粘度と速い生体分解速度を有することにより前記PEGより先に分解されて前記高分子網目の体内分解を促進させる天然高分子添加剤と、
前記PEGの光重合を開始するためのラジカルを生成する光重合開始剤と、を含み、
前記天然高分子添加剤は、ヒアルロン酸とコラーゲンの組み合わせが用いられ、分子量が100,000〜10,000,000であり、
前記PEGは、〔(−CH2CH2O−)n(ここでnは10〜1,000の自然数)〕の化学式を有し、前記分子量範囲内で直鎖状(2−arm)、分枝状(4または8−arm)、星状(multi−arm)のPEGが単独または混合して使用され、
前記光重合が可能な官能基は、アクリレート、メタクリレート、クマリン、チミン及びシンナマートのいずれか一つ以上を含み、
骨再生が完成された後、前記天然高分子添加剤が相互侵入高分子網目内で前記PEGより先に分解されて前記高分子網目の体内分解を促進させ、
骨欠損部に適用されることを特徴とする水和ゲルメンブレイン。 - I)光重合が可能な官能基を有するポリエチレングリコール(polyethylene glycol:以下、PEGと略す)を含む第1の液型及び、光重合されたPEGと一緒に相互侵入高分子網目 (interpenetrating polymer network:IPN)を形成し、前記PEGより高い粘度と速い生体分解速度を有することにより前記PEGより先に分解されて前記高分子網目の体内分解を促進させる天然高分子添加剤と前記PEGの光重合を開始するためのラジカルを生成する光重合開始剤とを含む第2の液型を準備する段階と、
II)前記準備された第1の液型と第2の液型を空洞部内で混合する段階と、
III)前記混合溶液をメンブレイン形態で形象化する段階と、
IV)前記メンブレインに可視光線を照射して相互侵入高分子網目(IPN)形態の水和ゲルを形成する段階と、を含み、
前記天然高分子添加剤は、ヒアルロン酸とコラーゲンの組み合わせが用いられ、分子量が100,000〜10,000,000であり、
前記PEGは、〔(−CH2CH2O−)n(ここでnは10〜1,000の自然数)〕の化学式を有し、前記分子量範囲内で直鎖状(2−arm)、分枝鎖状(4または8−arm)、星状(multi−arm)のPEGが単独または混合して使用され、
前記光重合が可能な官能基は、アクリレート、メタクリレート、クマリン、チミン及びシンナマートのいずれか一つ以上を含み、
骨再生が完成された後、前記天然高分子添加剤が相互侵入高分子網目内で前記PEGより先に分解されて前記高分子網目の体内分解を促進させ、
骨欠損部に適用されることを特徴とする水和ゲルメンブレインの製造方法。 - I)光重合が可能な官能基を有するポリエチレングリコール(polyethylene glycol:以下、PEGと略す)を含む第1の液型及び、前記PEGより高い粘度と速い生体分解速度を有する天然高分子添加剤と前記PEGの光重合を開始するためのラジカルを生成する光重合開始剤とを含む第2の液型を準備する段階と、
II)前記準備された第1の液型と第2の液型を空洞部内で混合する段階と、
III)前記混合溶液に可視光線を照射して相互侵入高分子網目(IPN)形態の水和ゲルを形成する段階と、
IV)前記水和ゲルをメンブレイン形態で形象化する段階と、を含み、
前記天然高分子添加剤は、ヒアルロン酸とコラーゲンの組み合わせが用いられ、分子量が100,000〜10,000,000であり、
前記PEGは、〔(−CH2CH2O−)n(ここでnは10〜1,000の自然数)〕の化学式を有し、前記分子量範囲内で直鎖状(2−arm)、分枝鎖状(4または8−arm)、星状(multi−arm)のPEGが単独または混合して使用され、
前記光重合が可能な官能基は、アクリレート、メタクリレート、クマリン、チミン及びシンナマートのいずれか一つ以上を含み、
骨再生が完成された後、前記天然高分子添加剤が相互侵入高分子網目内で前記PEGより先に分解されて前記高分子網目の体内分解を促進させ、
骨欠損部に適用されることを特徴とする水和ゲルメンブレインの製造方法。 - 前記光重合開始剤は、400〜750nm波長の可視光線に反応してラジカルを生成することを特徴とする請求項5または請求項6に記載の水和ゲルメンブレインの製造方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2011-0139849 | 2011-12-22 | ||
KR1020110139849A KR101269423B1 (ko) | 2011-12-22 | 2011-12-22 | 체내 분해 속도 조절이 가능한 수화젤 및 그 제조 방법 |
PCT/KR2012/008017 WO2013094858A1 (ko) | 2011-12-22 | 2012-10-04 | 체내 분해 속도 조절이 가능한수화젤 및 그 제조 방법 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015502829A JP2015502829A (ja) | 2015-01-29 |
JP2015502829A5 JP2015502829A5 (ja) | 2015-03-19 |
JP5837996B2 true JP5837996B2 (ja) | 2015-12-24 |
Family
ID=48667186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014548646A Active JP5837996B2 (ja) | 2011-12-22 | 2012-10-04 | 水和ゲル及び水和ゲルメンブレイン並びにそれらの製造方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20150005395A1 (ja) |
EP (1) | EP2796486A4 (ja) |
JP (1) | JP5837996B2 (ja) |
KR (1) | KR101269423B1 (ja) |
CN (1) | CN104011113B (ja) |
WO (1) | WO2013094858A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102492730B1 (ko) * | 2015-10-02 | 2023-01-27 | 삼성디스플레이 주식회사 | 유기 발광 표시 장치 |
KR102063210B1 (ko) * | 2017-12-19 | 2020-01-08 | 주식회사 테라시온 바이오메디칼 | 일시적 혈관폐쇄 용구의 제조방법 |
CA3137987A1 (en) * | 2019-05-07 | 2020-11-12 | Roquette Freres | Novel polysaccharide-based hydrogel scaffolds for wound care |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT627911E (pt) | 1992-02-28 | 2001-04-30 | Univ Texas | Hidrogeis biodegradaveis fotopolimerizaveis como materiais de contacto de tecidos e veiculos de libertacao controlada |
US5904927A (en) * | 1997-03-14 | 1999-05-18 | Northeastern University | Drug delivery using pH-sensitive semi-interpenetrating network hydrogels |
ATE407975T1 (de) * | 2000-11-28 | 2008-09-15 | Genzyme Corp | Die viskosität von polyalkylenglykol erhöhende polymere formulierungen |
JP4340067B2 (ja) * | 2001-04-23 | 2009-10-07 | ウィスコンシン アルムニ リサーチ ファウンデイション | 二機能性改変ハイドロゲル |
US20070212385A1 (en) * | 2006-03-13 | 2007-09-13 | David Nathaniel E | Fluidic Tissue Augmentation Compositions and Methods |
US7935363B2 (en) * | 2006-12-12 | 2011-05-03 | Synthasome, Inc. | Composite material for tissue repair |
US20110104280A1 (en) * | 2009-05-20 | 2011-05-05 | Olexander Hnojewyj | Wound treatment systems, devices, and methods using biocompatible synthetic hydrogel compositions |
US8697111B2 (en) * | 2010-05-12 | 2014-04-15 | Covidien Lp | Osteochondral implant comprising osseous phase and chondral phase |
US8591950B2 (en) * | 2010-05-27 | 2013-11-26 | Covidien Lp | Hydrogel implants with varying degrees of crosslinking |
US9265830B2 (en) * | 2011-04-20 | 2016-02-23 | Warsaw Orthopedic, Inc. | Implantable compositions and methods for preparing the same |
-
2011
- 2011-12-22 KR KR1020110139849A patent/KR101269423B1/ko active IP Right Grant
-
2012
- 2012-10-04 WO PCT/KR2012/008017 patent/WO2013094858A1/ko active Application Filing
- 2012-10-04 JP JP2014548646A patent/JP5837996B2/ja active Active
- 2012-10-04 CN CN201280063874.0A patent/CN104011113B/zh active Active
- 2012-10-04 EP EP12860012.9A patent/EP2796486A4/en not_active Withdrawn
- 2012-10-04 US US14/367,906 patent/US20150005395A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN104011113B (zh) | 2016-08-17 |
JP2015502829A (ja) | 2015-01-29 |
WO2013094858A1 (ko) | 2013-06-27 |
KR101269423B1 (ko) | 2013-05-30 |
CN104011113A (zh) | 2014-08-27 |
EP2796486A1 (en) | 2014-10-29 |
US20150005395A1 (en) | 2015-01-01 |
EP2796486A4 (en) | 2015-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Functional hydrogels with tunable structures and properties for tissue engineering applications | |
CN105169483B (zh) | 一种脱细胞基质凝胶的制备方法及其脱细胞基质凝胶 | |
US10099430B2 (en) | Three-dimensional printing process for producing a self-destructible temporary structure | |
Alizadeh et al. | Microstructure and characteristic properties of gelatin/chitosan scaffold prepared by a combined freeze-drying/leaching method | |
CN107663377B (zh) | 一种具有温敏和光敏特性的混合水凝胶及其3d打印方法 | |
CN103739862B (zh) | 明胶/羧甲基壳聚糖/poss光交联水凝胶及制备方法 | |
Lapomarda et al. | Pectin-GPTMS-based biomaterial: Toward a sustainable bioprinting of 3D scaffolds for tissue engineering application | |
Lee et al. | Engineered cartilage covered ear implants for auricular cartilage reconstruction | |
CN109821075B (zh) | 一种生物材料及其制备方法与作为骨缺损修复材料的应用 | |
KR101983741B1 (ko) | 바이오 잉크 및 이의 제조방법 | |
JP2008508959A5 (ja) | ||
CN106310380B (zh) | 一种纳米纤维化丝素蛋白凝胶及其制备方法 | |
CN106693050B (zh) | 一种基于胶原及胶原纤维的复合支架材料的制备方法 | |
CN105238132A (zh) | 一种用于3d打印的生物墨水 | |
Wu et al. | Novel digital light processing printing strategy using a collagen-based bioink with prospective cross-linker procyanidins | |
JP5837996B2 (ja) | 水和ゲル及び水和ゲルメンブレイン並びにそれらの製造方法 | |
Khoshnood et al. | Development of novel alginate‐polyethyleneimine cell‐laden bioink designed for 3D bioprinting of cutaneous wound healing scaffolds | |
JP2015502829A5 (ja) | ||
CN114316167B (zh) | 可负载间充质干细胞上清液成分的可注射光增强自愈合水凝胶及其制备方法 | |
Jongprasitkul et al. | Sequential cross-linking of gallic acid-functionalized GelMA-based bioinks with enhanced printability for extrusion-based 3D bioprinting | |
Wang et al. | Cryoprinting of nanoparticle-enhanced injectable hydrogel with shape-memory properties | |
CN107397980A (zh) | 一种组织修复膜涂覆用防粘连组合物及其使用方法 | |
CN103007342A (zh) | 生物可降解医用磷酸三钙/γ-聚谷氨酸复合材料及其制备方法 | |
John et al. | Nanocellulose-based hydrogels for biomedical applications | |
CN105646893A (zh) | 一种基于甲基乙烯基醚马来酸共聚物/氧化海藻酸钠可注射自愈合水凝胶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141209 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150602 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150902 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151027 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151106 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5837996 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |